The 25-year follow-up of the GÖTEBORG-1 trial 5 assessing active surveillance for screen-detected low and intermediate risk ...
Hosted on MSN
Sussex patients receiving cutting-edge prostate cancer treatments as part of national trial
The national trial, STAMPEDE2, is being run at the Royal Sussex County Hospital, Brighton, by a multidisciplinary team of clinicians at University Hospitals Sussex NHS Foundation Trust (UHSussex), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results